Company Filing History:
1 out of 1,384 
1 out of 402 
1 out of 3 Years Active: 1991-1992
Title: Inventor Dagne L Florine: Pioneering Innovations in Healthcare
Introduction
Dagne L Florine is a prominent inventor based in Moraga, California, known for her significant contributions to healthcare through her innovative patents. With two patents to her name, she has made strides in the treatment and prevention of severe medical conditions, particularly those induced by cancer therapies.
Latest Patents
Dagne's latest patents focus on groundbreaking methods in medical treatment. One of her key inventions addresses the treatment and prevention of oral mucositis, a painful side effect often resulting from chemotherapy and radiotherapy. The patent provides methods for administering effective doses of growth factors, such as TGF-alpha, either alone or in combination with other growth factors, to combat this condition. The recommended dose falls within the range of about 0.01-100 µg/dose, to be administered two to four times daily.
Her second patent presents synthetic peptides and antibodies that represent critical epitopic sites recognized by the human monoclonal antibody which can neutralize HTLV-I. This invention holds potential for diagnostics, therapeutics, and vaccine development related to HTLV-I, showcasing her versatility in tackling various medical challenges.
Career Highlights
Dagne L Florine has built an impressive career within the pharmaceutical and research sectors. She has worked with notable organizations such as Schering Aktiengesellschaft and Virginia Commonwealth University, where she has contributed her expertise and innovative thought processes to advance healthcare solutions. Her research has not only improved treatment methodologies but has also laid the groundwork for future discoveries in the field.
Collaborations
Throughout her career, Dagne has collaborated with esteemed colleagues, including Thomas J Smith and Robert W Akita. These partnerships have allowed her to expand the impact of her inventions, drawing on diverse expertise to foster innovative solutions that enhance medical treatments and patient care.
Conclusion
Dagne L Florine exemplifies the spirit of innovation within the healthcare sector through her pioneering patents and collaborative efforts. Her work in preventing and treating conditions such as oral mucositis and developing diagnostic tools for HTLV-I is a testament to her commitment to improving human health. As she continues to advance her research, Dagne remains an inspiring figure in the landscape of medical innovation.